leadf
logo-loader
viewAshmore Group

Ashmore profits surge on strong inflows as emerging markets rally

Even though emerging markets have been volatile, returns have remained good

Ashmore Group -
Seed capital portfolio chipped in a profit of £8.4mln

Emerging markets fund manager Ashmore PLC’s (LON:ASHM) profits surged 42% higher on the back of more strong inflows in the six months to December.

Assets under management rose by 28% year-on-year and by 7% from June with net inflows of US$5.7bn and investment gains of US$0.9bn lifting the total to US$98.4bn.

That translated into a 20% rise in revenues to £177mln, while profits jumped to £132mln from £93mln.

Even though emerging markets have been volatile, returns have remained good said Ashmore and continued a rally that started in 2016.

While there was disruption it tended to be country-centric in Argentina, Bolivia, Chile, Ecuador and Lebanon and there was a strong recovery in asset prices near the end of the period as some of these political situations began to normalise.

Mark Coombs, chief executive said: “There continue to be compelling incentives for investors to increase their allocations to Emerging Markets in pursuit of higher risk-adjusted returns compared with those that are available in the developed world.

“The strong client flow momentum in the first half of the financial year and ongoing client activity levels, mean Ashmore is well-positioned to continue to grow."

Ashmore raised the interim dividend by 5% to 4.80p.

Shares increased by 3% to 570p. 

Quick facts: Ashmore Group

Price: 372.4 GBX

LSE:ASHM
Market: LSE
Market Cap: £2.65 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

4D pharma plc merges with SPAC company Longevity Acquisition Corp

4D pharma plc (LON:DDDD) CEO Duncan Peyton tells Proactive the group is to get a cash injection of US$14.6mln through a merger with Longevity Acquisition Corporation (NASDAQ:LOAC), a special purpose acquisition company. Peyton says the merger will accelerate and de-risk 4D's admission to...

4 hours, 28 minutes ago

2 min read